CNTA
Price
$15.51
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
13 days until earnings call
RARE
Price
$53.07
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
106 days until earnings call
Ad is loading...

CNTA vs RARE

Header iconCNTA vs RARE Comparison
Open Charts CNTA vs RAREBanner chart's image
Centessa Pharmaceuticals
Price$15.51
Change-$0.00 (-0.00%)
Volume$127.92K
CapitalizationN/A
Ultragenyx Pharmaceutical
Price$53.07
Change-$0.00 (-0.00%)
Volume$922.89K
CapitalizationN/A
View a ticker or compare two or three
CNTA vs RARE Comparison Chart
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CNTA vs. RARE commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Buy and RARE is a Hold.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (CNTA: $15.51 vs. RARE: $52.80)
Brand notoriety: CNTA and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 19% vs. RARE: 97%
Market capitalization -- CNTA: $2.06B vs. RARE: $5.12B
CNTA [@Biotechnology] is valued at $2.06B. RARE’s [@Biotechnology] market capitalization is $5.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNTA and RARE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 3 TA indicator(s) are bullish while RARE’s TA Score has 3 bullish TA indicator(s).

  • CNTA’s TA Score: 3 bullish, 4 bearish.
  • RARE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CNTA is a better buy in the short-term than RARE.

Price Growth

CNTA (@Biotechnology) experienced а -1.77% price change this week, while RARE (@Biotechnology) price change was -3.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

CNTA is expected to report earnings on Mar 27, 2025.

RARE is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($5.12B) has a higher market cap than CNTA($2.06B). CNTA YTD gains are higher at: 94.849 vs. RARE (10.414). CNTA has higher annual earnings (EBITDA): -146.72M vs. RARE (-486.94M). RARE has more cash in the bank: 764M vs. CNTA (295M). RARE has less debt than CNTA: RARE (37.5M) vs CNTA (85.6M). RARE has higher revenues than CNTA: RARE (481M) vs CNTA (6.85M).
CNTARARECNTA / RARE
Capitalization2.06B5.12B40%
EBITDA-146.72M-486.94M30%
Gain YTD94.84910.414911%
P/E RatioN/AN/A-
Revenue6.85M481M1%
Total Cash295M764M39%
Total Debt85.6M37.5M228%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTARARE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with RARE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then RARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
+0.06%
RARE - CNTA
39%
Loosely correlated
-1.39%
OCUL - CNTA
38%
Loosely correlated
+2.06%
XNCR - CNTA
38%
Loosely correlated
+1.94%
SNDX - CNTA
37%
Loosely correlated
+2.45%
LRMR - CNTA
37%
Loosely correlated
+0.06%
More